An ‘Epic’ pushback as U.S. prepares for new era of empowering patient health data
Epic, the largest electronic health record company in the U.S., launched an effort last week to persuade hospital CEOs across the country to fight recent efforts by the federal government to ensure that patients can easily access their electronic health data.Source: STAT
YSPH Collaborating with China to Develop New Medical Payment Models
Improving China’s medical payment models was the topic of discussion when Yale School of Public Health Dean Sten H. Vermund traveled to Beijing in January 2019 to meet with officials from China’s National Health Commission as part of the country’s ongoing healthcare reform efforts.
Zack Cooper Receives Carnegie Fellowship to Support Research on Drug Pricing
Health economist Zack Cooper, associate professor at the Yale School of Public Health and in the Department of Economics, is one of 32 recipients of this year’s Andrew Carnegie Fellowship, awarded by the Carnegie Corporation of New York.
Community input sought in New Haven diversion program
Nearly a year after the city implemented its harm reduction program, LEAD, it’s reaching out to involve the community in the effort. Sophie Wheelock, a master's of public health candidate t at the Yale School of Public Health worked on a report presented to the community in September.Source: Chron
Yale joins the ‘surge’ to prepare African scientists to lead HIV treatment and prevention
South Africa has the largest HIV epidemic in the world, with an estimated 7.1 million infected individuals. National and global commitment to a “surge” — rapid expansion of HIV/AIDS and TB treatment and prevention throughout the country — will significantly increase the demand for researchers with expertise in areas such as implementation science who can define best practices and influence effective policy.
Infant Health is the Top Priority
Breastfeeding (BF) support is one of the most cost-effective interventions to advance mother–child health worldwide. Large-scale BF support may prevent 11.6% of infant deaths and improves cognitive development. Read the joint statement from Dean Sten Vermund and Rafael Pérez-Escamilla.
Viral Suppression Helps Lower Risk for Many Types of Cancer, Study Finds.
A new study by the Yale School of Public Health and partner institutions is the first to examine the potential cancer prevention benefits of prolonged periods of HIV viral suppression, resulting from antiretroviral therapy, for persons living with HIV.
Yale School of Public Health to Offer Online Climate Change and Health Certificate
The Yale School of Public Health will offer a new 18-week, online certificate program on climate change and health beginning in September 2018-the first online certificate program focused on this topic offered by a U.S. school of public health.
New cancer immunotherapy drugs rapidly reach patients after approval
The majority of patients eligible for cancer immunotherapy drugs known as checkpoint inhibitors received treatment within a few months of FDA approval, according to a new Yale-led study. The finding suggests that cancer immunotherapies are adopted at a much quicker pace than is typical for newly approved medical treatments, the researchers said. However, patients receiving the therapies are older than those in the clinical trials used to evaluate them, pointing to a disconnect between research and practice that should be addressed, they noted.
Yale-developed plan to curb opioid overdose crisis helps state, nation
The opioid addiction and overdose epidemic continues to take the lives of too many Americans. Of the nearly 64,000 overdose deaths reported in 2016, almost two-thirds involved a prescription or illicit opioid. Yale faculty have confronted the crisis in myriad ways, including research that impacts policy and medical practice.
Low-cost anti-hookworm drug boosts female farmers’ physical fitness
Impoverished female farm workers infected with intestinal parasites known as hookworms saw significant improvements in physical fitness when they were treated with a low-cost deworming drug. The benefits were seen even in those with low level infections, according to a study co-authored by researchers at Yale and the nonprofit company InnovationsCZ.
Scientist, Journalist and Filmmaker Converge on YSPH to Explore the Threat of Climate Change
Climate change was in the air Wednesday as three separate speakers-a scholar, journalist, and a filmmaker-converged at the Yale School of Public Health to explore the implications of climate change on human health in the coming decades.
Update on Yale’s Primary Health Care Transformation Initiative in Ethiopia
In 2016, a team from Yale’s Global Health Leadership Institute partnered with Ethiopia’s Ministry of Health to launch the Primary Health Care Transformation Initiative (PTI). Since its inception, PTI has seen improvements in management systems. Those successes have since led to an expansion of the program to impact 331 districts by the end of 2019, serving a population of 47 million people.
Affordable Care Act lowered uninsured rate for cancer survivors
The percentage of cancer survivors without health insurance decreased substantially after implementation of the Affordable Care Act (ACA), reports a study in the March issue of Medical Care, published by Wolters Kluwer. Cancer survivors eligible for Medicaid expansion under the ACA had the greatest decrease in uninsured rate, according to the new research by Amy J. Davidoff, PhD, of Yale School of Public Health, New Haven, Conn., and colleagues. They write, "ACA implementation was associated with large coverage gains in targeted expansion groups, including cancer survivors, but additional progress is needed."Source: Eurekaalert
Long-dreaded Amazon threat to drug middlemen draws closer
Amazon.com is joining with Berkshire Hathaway and JPMorgan Chase & Co. to form a new health-care business, an attempt by three of the world's best-known companies to contain the spiraling cost of keeping their U.S. workers healthy. Zach Cooper, an economist at the Yale School of Public Health, wonders if this new initiative will succeed.Source: Chicago Tribune
Yale & ACS paper makes it to The Most Discussed and Shared JCO Articles of 2017
A study published by Yale COPPER Center’s Amy J. Davidoff, PhD and colleagues at the American Cancer Society (ACS) has made it to The Most Discussed and Shared JCO Articles of 2017, a list of the top-10 articles with the highest Altmetric Attention Scores, which measure the quality and quantity of online attention received.